Skip to main content
Abpro Bio Co., Ltd. logo

Abpro Bio Co., Ltd. — Investor Relations & Filings

Ticker · 195990 ISIN · KR7195990007 KO Manufacturing
Open in API
Filings indexed 430 across all filing types
Latest filing 2020-04-07 Capital/Financing Update
Country KR South Korea
Listing KO 195990

About Abpro Bio Co., Ltd.

https://abpro.co/

Abpro Bio Co., Ltd. is a company engaged in the manufacture and sale of precision machine tools. Its primary products include tapping centers, 2-spindle machining centers, and other specialized industrial machinery. In addition to its core manufacturing operations, the company has diversified its business to include a biotechnology division. This division is involved in the development of next-generation antibody therapeutics, often through exclusive development agreements and collaborations with strategic partners.

Recent filings

Filing Released Lang Actions
전환청구권행사(제11회차, 제12회차)
Capital/Financing Update Classification · 95% confidence The document is a regulatory filing from a Korean company (Abiopro Bio) detailing the exercise of conversion rights (전환청구권행사) for convertible bonds (CB). This involves the issuance of new shares resulting from the conversion of debt into equity, which directly impacts the company's capital structure and share count. According to the provided definitions, this falls under 'Share Issue/Capital Change' (SHA) as it relates to the issuance of new shares via conversion.
2020-04-07 Korean
[기재정정]사업보고서 (2019.12)
Annual Report Classification · 95% confidence The document is a 'Correction Report' (정정신고) for an 'Annual Report' (사업보고서) filed by Abpro Bio. It contains detailed financial tables (consolidated and separate statements of comprehensive income) and corporate information, which are characteristic of an Annual Report (10-K). Although it is a correction filing, it serves as the official annual financial disclosure for the company for the fiscal year 2019. FY 2019
2020-03-31 Korean
[기재정정]타법인주식및출자증권취득결정(종속회사의주요경영사항)
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from the Korea Exchange (KRX) system, specifically a 'Correction Report' (정정신고) regarding a previous decision to acquire shares in another company (Abpro Corporation). This type of filing, which details changes to investment terms, acquisition schedules, and financial impacts on the parent company, falls under the category of general regulatory announcements for corporate actions that do not fit into specific categories like M&A (which usually implies a full takeover or merger) or share issuance. Given the nature of the disclosure as a formal regulatory update on a subsidiary's investment activity, it is classified as a Regulatory Filing (RNS).
2020-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, dividend decisions, and board appointments. This aligns perfectly with the definition of a Declaration of Voting Results (DVA).
2020-03-30 Korean
사업보고서 (2019.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the fiscal year 2019 (2019.01.01-2019.12.31) for Abpro Bio Co., Ltd. It contains comprehensive company information, including financial data, management details, capital changes, and shareholding information. In the context of Korean regulatory filings (DART), a 'Business Report' (사업보고서) is the equivalent of an Annual Report (10-K). FY 2019
2020-03-30 Korean
주주총회집중일개최사유신고
AGM Information Classification · 95% confidence The document is a formal regulatory filing submitted to the KRX (Korea Exchange) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company scheduled its AGM on a date that coincides with many other companies, citing internal scheduling constraints. Since this is a specific regulatory disclosure regarding meeting logistics rather than the meeting materials themselves or a proxy statement, it falls under the general regulatory filing category.
2020-03-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.